PortfoliosLab logoPortfoliosLab logo
^SPXHC vs. EW
Performance
Return for Risk
Drawdowns
Volatility

Performance

^SPXHC vs. EW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in S&P 500 Health Care Index (^SPXHC) and Edwards Lifesciences Corporation (EW). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

^SPXHC vs. EW - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
^SPXHC
S&P 500 Health Care Index
-4.53%12.53%0.90%0.30%-3.55%24.16%11.43%18.68%4.69%20.00%
EW
Edwards Lifesciences Corporation
-4.68%15.16%-2.91%2.20%-42.41%42.00%17.32%52.31%35.90%20.29%

Returns By Period

The year-to-date returns for both stocks are quite close, with ^SPXHC having a -4.53% return and EW slightly lower at -4.68%. Over the past 10 years, ^SPXHC has underperformed EW with an annualized return of 8.06%, while EW has yielded a comparatively higher 10.49% annualized return.


^SPXHC

1D
0.80%
1M
-6.58%
YTD
-4.53%
6M
3.06%
1Y
3.08%
3Y*
4.50%
5Y*
4.90%
10Y*
8.06%

EW

1D
1.47%
1M
-6.79%
YTD
-4.68%
6M
6.49%
1Y
13.07%
3Y*
-0.60%
5Y*
-0.62%
10Y*
10.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

^SPXHC vs. EW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

^SPXHC
^SPXHC Risk / Return Rank: 1919
Overall Rank
^SPXHC Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
^SPXHC Sortino Ratio Rank: 2020
Sortino Ratio Rank
^SPXHC Omega Ratio Rank: 1919
Omega Ratio Rank
^SPXHC Calmar Ratio Rank: 1818
Calmar Ratio Rank
^SPXHC Martin Ratio Rank: 1919
Martin Ratio Rank

EW
EW Risk / Return Rank: 5858
Overall Rank
EW Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
EW Sortino Ratio Rank: 5454
Sortino Ratio Rank
EW Omega Ratio Rank: 5151
Omega Ratio Rank
EW Calmar Ratio Rank: 6262
Calmar Ratio Rank
EW Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

^SPXHC vs. EW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for S&P 500 Health Care Index (^SPXHC) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


^SPXHCEWDifference

Sharpe ratio

Return per unit of total volatility

0.18

0.55

-0.37

Sortino ratio

Return per unit of downside risk

0.36

0.98

-0.61

Omega ratio

Gain probability vs. loss probability

1.05

1.11

-0.07

Calmar ratio

Return relative to maximum drawdown

0.12

0.95

-0.83

Martin ratio

Return relative to average drawdown

0.24

2.63

-2.39

^SPXHC vs. EW - Sharpe Ratio Comparison

The current ^SPXHC Sharpe Ratio is 0.18, which is lower than the EW Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of ^SPXHC and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


^SPXHCEWDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.18

0.55

-0.37

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.34

-0.02

+0.36

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.49

0.32

+0.17

Sharpe Ratio (All Time)

Calculated using the full available price history

0.36

0.51

-0.15

Correlation

The correlation between ^SPXHC and EW is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Drawdowns

^SPXHC vs. EW - Drawdown Comparison

The maximum ^SPXHC drawdown since its inception was -40.78%, smaller than the maximum EW drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for ^SPXHC and EW.


Loading graphics...

Drawdown Indicators


^SPXHCEWDifference

Max Drawdown

Largest peak-to-trough decline

-40.78%

-54.32%

+13.54%

Max Drawdown (1Y)

Largest decline over 1 year

-10.86%

-12.73%

+1.87%

Max Drawdown (5Y)

Largest decline over 5 years

-18.01%

-54.32%

+36.31%

Max Drawdown (10Y)

Largest decline over 10 years

-28.59%

-54.32%

+25.73%

Current Drawdown

Current decline from peak

-7.52%

-37.82%

+30.30%

Average Drawdown

Average peak-to-trough decline

-8.32%

-14.31%

+5.99%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.38%

4.61%

+0.77%

Volatility

^SPXHC vs. EW - Volatility Comparison

The current volatility for S&P 500 Health Care Index (^SPXHC) is 4.73%, while Edwards Lifesciences Corporation (EW) has a volatility of 7.95%. This indicates that ^SPXHC experiences smaller price fluctuations and is considered to be less risky than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


^SPXHCEWDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.73%

7.95%

-3.22%

Volatility (6M)

Calculated over the trailing 6-month period

10.21%

17.43%

-7.22%

Volatility (1Y)

Calculated over the trailing 1-year period

17.67%

24.02%

-6.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.56%

32.49%

-17.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.58%

32.59%

-16.01%